Hypnotherapy App vs a Real Hypnotherapist: When Each One Wins

The short version. Apps are right for some cases, in-person work is right for others, and a sequenced approach (try the app first, upgrade if it does not move the needle) is the cheapest realistic path for many people. The point of this page is to be specific about which case is which, name the apps that are worth considering, and put the budget conversation on the table without pretending one tool wins across the board.

The honest comparison most marketing won't give you

If you read app marketing, an app is always sufficient and the in-person practitioner category is a legacy expense. If you read practitioner marketing, the app is a toy and only in-person work counts. Both framings are wrong, and both are wrong in ways that cost the reader money or time. The version I think is honest, after working with hundreds of clients in Calgary and virtually across Canada, is more boring and more useful. The right tool depends on the case in front of you.

A few things to put on the table early. Hypnosis apps have gotten meaningfully better in the last five years. Reveri is built by one of the most-cited clinical hypnosis researchers of the last forty years. Nerva is built around a research protocol developed at a major university gastroenterology program. Mahana cleared a regulatory bar that the rest of the category has not. Pretending those products are not real would be silly. Pretending they replace personalized in-person work for every presentation would be equally silly.

The pricing gap is also real and worth being explicit about. A typical hypnosis app subscription is in the range of ten to twenty-five dollars a month. A single in-person session with a credentialed practitioner is in the range of one hundred and fifty to two hundred and fifty dollars depending on geography. Sessions at the practice I run are two hundred and twenty dollars. Across a year, an app costs roughly one hundred and eighty dollars and a course of in-person work might cost between eight hundred and two thousand. That gap is not a tie-breaker on its own, but pretending it is not there would be dishonest, and it shapes the right move for a lot of readers.

The other thing this page covers explicitly. The sequenced approach. Many readers are best served by spending fifteen dollars on a thirty day app trial first, then deciding based on what happened in that trial whether to keep using the app, switch to a more condition-specific app, or upgrade to in-person work. That sequence is the cheapest realistic path for the cases where it applies, and it is under-covered in the search results because neither side of the marketing fight has an incentive to recommend it.

Worth saying upfront. I am a Registered Clinical Hypnotherapist whose service competes with the in-person column in this comparison. The bias is real and I have tried to manage it the same way I did in the dedicated Reveri review. By being explicit about the cases where an app is the right tool and the reader should not book in-person work, including cases where a less honest version of this page would push toward in-person regardless. If parts of this read like an argument for staying with the app, that is the feature, not the bug.

The current app landscape

Reveri is the strongest general-purpose pick. Built by Dr. David Spiegel, professor of psychiatry at Stanford and one of the most-cited clinical hypnosis researchers of the last forty years. The app launched in 2020, raised venture capital, and is positioned as a research-anchored alternative to general meditation apps. The library covers stress and anxiety, sleep, focus and performance, pain management, and habit change including smoking and eating patterns. Sessions are typically eight to fifteen minutes, voiced primarily by Spiegel, and updated regularly. Pricing is around fifteen dollars a month with annual discounts. The app also includes a digital adaptation of the Hypnotic Induction Profile, the suggestibility instrument Spiegel himself developed, which lets a user check whether they sit in the moderate to high responsiveness range or in the roughly fifteen percent of the population that scores low.

Nerva is the strongest IBS-specific pick. Built around the gut-directed hypnotherapy protocol developed at Monash University in Melbourne, which is one of the strongest condition-specific evidence bases in the entire hypnosis literature. Nerva runs as a structured 6 week program, which mirrors how gut-directed hypnotherapy is delivered in person, rather than as an on-demand library. Pricing is roughly the same as Reveri. For an IBS-only use case, Nerva is more targeted than Reveri's general content. Where this matters in practice is that the gut-directed protocol uses suggestions specifically aimed at gut sensitivity, gut-brain communication, and visceral hypersensitivity, which are mechanisms a generic stress or relaxation track does not address head-on.

Mahana is the other IBS-focused option. Mahana takes a similar gut-directed framing to Nerva, runs as a structured 12 week program, and is FDA-cleared as a digital therapeutic for IBS in the United States. The FDA clearance is a regulatory marker that the other apps do not have, and it implies a level of evidence-of-effectiveness review that the generic wellness app category has not been through. In Canada the practical difference between Nerva and Mahana for an IBS user is modest, and the right choice usually comes down to which program structure feels more usable. Either is a more targeted IBS choice than Reveri's general content.

Mindset is more of a general wellness tool with less hypnosis-anchored content. It is built more around coaching and goal-tracking than around the focused attention plus suggestion mechanism that Reveri, Nerva, and Mahana use. For a user who specifically wants hypnosis as the technique, Reveri is the closer fit than Mindset. Mindset is a reasonable pick for a general-wellness habit-tracking use case, but it is not really competing with the hypnosis apps on mechanism.

Calm, Headspace, and Insight Timer are mindfulness meditation apps and are mentioned in the same conversations because they show up in the same app store searches. The mechanism is different. Mindfulness builds sustained, non-judgmental attention to present-moment experience. Hypnosis uses focused attention as a vehicle for targeted suggestion. The two overlap on the relaxation and breath onramp but diverge from there. Someone shopping for a hypnotherapy benefit should not buy a meditation app and expect it to do hypnosis work, and vice versa. The pricing band is similar, around ten to fifteen dollars a month, which is part of why the categories get conflated.

Worth being explicit about scope. As a Registered Clinical Hypnotherapist working within the ARCH code of conduct, I do not diagnose conditions and do not prescribe or adjust medication. App content sits on the same scope question. None of these apps diagnose, none of them prescribe, and any app that markets itself as treating a serious mental health condition without a credentialed practitioner involved is one to be cautious about.

What apps do well (genuinely)

Start with what apps get right, because the strengths are real and they explain why so many people get useful results from them.

Quality of induction is often very good. The induction is the part of a hypnosis session that brings attention into a focused, narrow, internally-oriented state. Most well-built apps are voiced by experienced clinicians or researchers, paced appropriately, and use suggestion language aligned with the research literature on what tends to land. None of those things are guaranteed in self-hypnosis content generally. Many free recordings online are made by people with light training, pacing that is too fast, suggestions that are imprecise, and production that is distracting. The well-built apps in the category are not in that group.

On-demand availability is real and matters. Three in the morning, wide awake, mind racing, looking for a sleep induction. The app delivers in under thirty seconds. No scheduling, no waitlist, no cancellation friction, no gatekeeper. For acute moments where the right tool is whatever works in the next five minutes, an on-demand library is the right format. No in-person practice can match that response time.

Pricing is accessible. Around fifteen dollars a month is the cost of a single coffee a week, and it is orders of magnitude cheaper than in-person sessions. For someone with mild general stress, occasional difficulty falling asleep, focus support around a deadline, or general habit support, the math is straightforward. The app is the more cost-rational starting point for problems that are mild and general. Even where in-person work would ultimately do more, the app trial is cheap enough to use as a screen.

For mild and general use cases, often sufficient. Most of the people I see in the practice who have used a hypnosis app for a while either continue using the app and never need in-person work, or they identify a specific pattern the app cannot reach and book in for that specific work. The first group is large and worth respecting. Many app users get real benefit and never need to upgrade. The cases that show up in my office are the second group, which means my view of the category is biased toward the cases where the app was not enough. Pretending the first group does not exist would be wrong.

Built-in suggestibility assessment is an underrated feature. Reveri specifically includes a digital adaptation of the Hypnotic Induction Profile so users can check whether they sit in the moderate to high responsiveness range or in the low range. That is meaningful self-knowledge that the rest of the meditation and wellness app category does not bother offering. Knowing your suggestibility profile shapes expectations about what any hypnosis-based intervention will do, app or in-person, and a few minutes of self-assessment up front is a sensible use of the format.

Consistency of practice is easier with an app. The friction to opening an app and pressing play is lower than the friction to scheduling, attending, and paying for an in-person session. Lower friction tends to translate to higher practice frequency. For hypnosis work where most of the benefit accrues through repeated practice over weeks rather than through a single high-stakes session, the practice volume the app encourages is a real asset. Some of the clients I work with use an app between in-person sessions for exactly this reason.

Where apps fall short (any app, not just one)

These limits are structural to the self-hypnosis app format. A library of pre-recorded sessions, no matter how well produced and no matter who voices it, cannot do certain things. The honest review names the limits clearly so the reader can decide whether they matter for the specific case.

No personalization to your specific clinical history. The app does not know whether you have had three previous panic episodes that responded to a specific kind of grounding, whether your insomnia started after a bereavement, whether your anxiety has a specific trigger that needs a specific desensitization, or whether your IBS flares track to a particular eating pattern. A practitioner can build the suggestion content around those facts. A library cannot.

No personalization to comorbidities. If you have anxiety stacked with IBS, insomnia stacked with chronic pain, OCD with health anxiety, or chronic pain with depression, the right approach to either layer changes when the other layer is present. App content treats each category as if it stood alone. In real practice, comorbidities reshape the plan. The interaction between gut symptoms and anxiety is one of the clearest examples, and we cover it in the page on the anxiety and IBS overlap where Nerva or Mahana may be the better app choice.

No interactive feedback. A live practitioner adjusts during the session. They notice when a suggestion is not landing and try a different angle. They notice when something emotional surfaces and slow the pace. They notice when the listener has gone deeper than expected and adjust the language for that depth. A pre-recorded session cannot do any of that. The recording plays the same way regardless of what is happening in the listener that day.

No troubleshooting when sessions stop working. A common pattern with self-hypnosis apps is initial benefit, followed by a plateau at four to six weeks, followed by gradual disengagement when the same content stops producing the same effect. A practitioner can troubleshoot that plateau. Try a different induction. Tighten the suggestion to a more specific behaviour. Add an emotional-processing layer if the surface work has done what it can. An app cannot make those calls. The library stays the same and the user is left to decide whether the modality has stopped working or just needs a different angle.

No scope-of-practice screening. This is the most important limit for the reader to understand. A credentialed practitioner is trained to recognize when a presentation is outside the scope of what hypnotherapy can responsibly address, and to refer the client to the right kind of care instead. Active suicidality, untreated severe trauma, psychotic-spectrum presentations, severe dissociative conditions, untreated bipolar in an affective phase. None of those are hypnotherapy presentations and a responsible practitioner will say so and refer out. An app does not do screening. It will serve the same library to a person with mild stress and a person in active crisis. That is a real risk for the small minority of users whose presentation needed to be redirected to a different kind of care from the start.

Limited depth per session. Eight to fifteen minutes is useful for stress reduction, sleep onset, and general state regulation. It is short relative to the fifty to ninety minute sessions of structured in-person clinical hypnotherapy work. The shorter format trades depth for accessibility. For mild presentations the trade is worth it. For deeper presentations the shorter format simply does not have time to do what needs doing in a single sitting.

Doesn't address the meta-anxiety layer. Many of the clients I see who have used self-hypnosis apps without getting traction have a specific issue. They start a session, notice that something is not landing, start doubting whether they are doing it right, get self-conscious about performing the exercise, and the doubt itself derails the work. The relationship with a practitioner resolves that loop because the practitioner can name what is happening, normalize it, and redirect. The app cannot. For users prone to that meta-pattern, the app can actively reinforce the doubt loop instead of breaking it.

No coordination with other care providers. A practitioner can communicate (with consent) with a GP, gastroenterologist, sleep physician, psychiatrist, or psychologist already involved in the client's care. That coordination matters when hypnotherapy is sitting alongside medication, CBT-I, ERP, or another treatment that needs the picture to fit together. App use is solo by design and the larger care team has no visibility into what the app is doing.

Condition-by-condition: app or in-person?

The honest answer for any specific reader is condition-specific, so this section is organized that way. Ten common reasons people consider hypnotherapy in the first place, with a practical recommendation on whether an app is enough, whether a sequenced approach makes sense, or whether in-person work is the right starting point.

General stress and mild anxiety

App is usually enough. The state-regulation work that hypnosis does for general stress and mild anxiety generalizes well from a generic recorded session. Reveri or a similar general-purpose app, used daily for two to four weeks, is often sufficient to take the edge off and build a sustainable practice. If the issue is genuinely mild and not part of a clinical anxiety presentation, upgrading to in-person work is rarely necessary. Where this changes is if the stress is sitting on top of a clinical anxiety condition that has not been named or addressed. In that case the right move is the evaluation, not more app sessions.

Sleep onset and mild insomnia

App is a reasonable starting point. Cordi 2014 (PMID 24882902) on slow-wave sleep aligns with the kind of audio-delivered hypnotic suggestion an app provides. For occasional difficulty falling asleep, the wired night, or generally improving sleep onset latency, Reveri's sleep category is well designed and often enough. The case where this is not enough is chronic multi-year insomnia, the three in the morning wake-up that does not resolve, or insomnia that has not responded to CBT-I. Those need personalized work and often need to be coordinated with a sleep physician.

IBS

Condition-specific apps first, in-person if the app trial does not move things. Nerva and Mahana have stronger condition-specific evidence for IBS than generic apps like Reveri because they are built around the gut-directed hypnotherapy protocol developed at Monash University. For an IBS user, starting with Nerva (or Mahana) for the full program length is a defensible first move. If symptoms meaningfully improve, that is the answer. If they do not, in-person gut-directed hypnotherapy is the next step, particularly if there is comorbid anxiety, severe symptom load, or symptoms that have not responded to dietary interventions like low FODMAP. We cover the comorbidity question in the page on the anxiety and IBS overlap where Nerva or Mahana may be the better app choice.

Severe chronic insomnia

In-person, with the app potentially playing a maintenance role later. Severe insomnia (multi-year, multiple symptom clusters, comorbid anxiety or depression, has not responded to CBT-I) needs a personalized plan, coordination with the rest of the care team, and troubleshooting that an app cannot provide. CBT-I remains the first-line evidence-based treatment for chronic insomnia, and clinical hypnotherapy sits as adjunct or alternative when CBT-I has failed or is unavailable. App use in the severe-insomnia case is sometimes useful as between-session reinforcement after the in-person work has set the foundation, not as the primary tool.

OCD

Never an app as primary. OCD's gold-standard treatment is exposure and response prevention (ERP), delivered by a trained psychologist or therapist. Hypnotherapy plays a small adjunctive role at most, helping with the anxiety regulation that surrounds the ERP work. App-only hypnosis for OCD is the wrong tool and can sometimes reinforce the very avoidance and reassurance-seeking patterns that ERP is trying to interrupt. If OCD is the presentation, the first step is finding an ERP-trained clinician, not picking an app.

PTSD and trauma

Never an app as primary. Trauma processing requires a trauma-trained practitioner who can monitor for dissociation, ground the client when something surfaces, and adjust the work in real time. Self-hypnosis apps used unsupervised by someone with a significant trauma history can accidentally surface material that the user is not equipped to process alone, which is the opposite of helpful. If trauma is in the picture, the first step is a trauma-aware practitioner. Hypnotherapy can play a supporting role later in the work, often around state regulation and between-session calm, but it is not the lead tool and an app is not the right delivery format.

Health anxiety

In-person likely better. Health anxiety has a meta-pattern (the anxiety about the body sensations is itself driving more body sensations, which drives more anxiety) that needs interactive work to interrupt. A generic app session aimed at general anxiety often misses the loop entirely. The work that resolves health anxiety usually involves some combination of interoceptive exposure, attention training, and careful suggestion work that is built around the specific pattern the client is in, which is exactly the kind of personalization an app cannot provide.

Specific phobia (single time-bound, like an MRI or a flight)

In-person beats app for the high-stakes single event. One to three preparation sessions with a practitioner aimed at the specific procedure or flight will outperform a generic phobia track on the app. The personalization is the whole point. If the event is weeks away and the budget supports it, in-person is the better call. If the event is days away, the budget is constrained, or in-person access is not possible, an app general-anxiety or focus track is better than nothing and may take the edge off.

Smoking cessation

Either can work, combined often strongest. Single-session hypnosis for smoking cessation has a real but modest evidence base, and an app smoking-cessation track can produce results for a motivated quitter. In-person smoking-cessation hypnosis is typically delivered as a single session with optional reinforcement, which is already a low-cost in-person option compared to other presentations. For the highest-leverage case, doing the in-person session first to anchor the quit and then using the app for daily reinforcement and craving management in the first thirty days is a sensible combined approach. Honest framing: real-world quit rates with hypnosis are modest, no responsible practitioner guarantees outcomes, and the same is true of the app.

Performance anxiety

Stakes-dependent. For modest performance situations (regular work presentations, recurring meetings, ongoing public speaking), an app focus and state-regulation track used consistently can do most of the work. For high-stakes performance with a specific anchor event (an audition, a major medical procedure as the patient, a high-pressure exam), in-person preparation work usually beats a generic track because the suggestions and the imagined rehearsals can be built around the specific event. The same logic applies for the procedural anxiety case where the Hammond 2010 (PMID 20183733) review supports hypnotherapy as an adjunctive intervention.

The sequenced approach (often the right answer)

The sequence I recommend most often, especially for readers who land between the clean app cases and the clean in-person cases, has four steps. It is the cheapest realistic path for a lot of presentations and it is under-discussed in the marketing on either side.

Step one. Pick a thirty day window and commit to a daily app practice. For general use, that is Reveri. For IBS specifically, that is Nerva or Mahana. Spend roughly fifteen dollars on the subscription. At day zero, score the target issue on a 0 to 10 scale (sleep quality, anxiety intensity, IBS symptom load, focus stability) and write the score down. Score it again every seven days.

Step two. At day thirty, look at the rating. If the score has dropped at least two points and you have practiced most days, the app is doing the work. Continue. There is no reason to upgrade. Many users in this branch never need in-person work.

Step three. If the score has not dropped meaningfully after thirty days of consistent practice, two questions are worth asking. Was the issue IBS specifically and did you use a generic app like Reveri rather than a condition-specific app like Nerva or Mahana? If yes, switch apps before assuming the issue is untreatable by an app. Was the issue something else that needs personalization, like clinical-grade anxiety, comorbid presentation, or a severe condition? If yes, an in-person consultation is the next step. The pattern of consistent practice without response usually signals that the case needs personalization the app cannot provide.

Step four. If you upgrade to in-person work, the app does not have to go away. Many of the clients I work with use the app between sessions for self-hypnosis practice and reinforcement. The pattern that works is in-person doing the personalized work (history, scope screening, individualized suggestions, troubleshooting when something stalls) and the app filling in the days between sessions. After the formal course of in-person work ends, the app often plays a sensible maintenance role for the months and years that follow.

The honest framing on this sequence. Most readers I see in the practice skipped the app trial and went straight to in-person work. Sometimes that was the right call (clearly diagnosed conditions, severe presentations, presentations needing scope screening). Sometimes the app trial would have settled the question for fifteen dollars and saved the in-person spend. Without the trial, the reader cannot tell which group they were in. The trial is cheap, the downside is small, and the information it generates is useful regardless of which way it points.

Per the published service structure for this practice, sessions are two hundred and twenty dollars CAD delivered virtually across Canada or in-person in Calgary. Standard initial commitments are typically three sessions for habit change, four to six sessions for anxiety and chronic pain work, and a single session with optional reinforcement for smoking cessation. There are no admin fees and a detailed receipt is provided with the practitioner's ARCH registration number. The budget side of the conversation deserves its own page, and we cover it in the guide on hypnotherapy pricing in Canada for the budget side of the decision.

What the research says about app vs clinician delivery

The honest summary first. Direct head-to-head app-versus-clinician randomized controlled trials for hypnotherapy specifically are sparse. Most of what we have is generalizable evidence from the broader hypnosis literature on one side and unaudited app-company user surveys on the other. Reading both honestly leaves a picture that is more nuanced than either side's marketing suggests.

Clinician-delivered hypnotherapy has the stronger overall evidence base. Across most clinical conditions where hypnosis has been studied, the existing trials use clinician-delivered protocols rather than app delivery. For IBS, the gut-directed hypnotherapy literature anchored at Monash University is built on clinician-delivered protocols. For procedural anxiety, the evidence base is built on clinician-delivered work in pre-procedural settings. For chronic pain adjunct, the work that has been studied is clinician-delivered. That does not mean app delivery cannot capture some of the same benefit. It means that when someone says hypnotherapy works for X, what they usually mean is clinician-delivered hypnotherapy works for X, and the app-monotherapy version is an extrapolation rather than a directly tested claim.

App-monotherapy evidence is thinner and mostly observational. Most of the public outcome numbers that hypnosis app companies cite come from in-app user surveys rather than independent randomized trials. The often-quoted Reveri figure of 90 percent of users felt more rested is the company's own unaudited number from in-app self-report. That is not validated research, and it should not be read as such. App companies in wellness more broadly publish their internal numbers and call them outcomes, but they are marketing data, not RCT evidence. Reading them as if they were RCT evidence inflates the case for the app category and mis-sets expectations for the user.

Cordi 2014 (PMID 24882902) is one of the cleaner pieces of evidence that does generalize partly to app delivery. The study used a tape-based audio protocol containing hypnotic suggestion, played before sleep to healthy young women who had been screened for high suggestibility. The intervention group showed approximately 81 percent more slow-wave sleep than control. The protocol structure (audio-delivered, non-personalized, played in self-administered fashion) is much closer to what an app provides than to fully personalized clinician work. So the finding does transfer reasonably to the case of a high-suggestibility user using sleep content from an app for general sleep support. The honest caveats. The study did not test clinical insomnia and it did not include low-suggestibility participants in the effect window. So it is not a license to claim apps cure insomnia. It is a defensible piece of evidence for the state-regulation slice of the use case.

Chamine 2018 (PMID 29952757) conducted a systematic review of clinical trials evaluating hypnosis interventions for sleep outcomes. Of 24 included trials, 13 (54 percent) reported a sleep benefit including improvements in sleep onset latency, total sleep time, and subjective sleep quality. The review included both clinician-delivered and self-administered hypnosis protocols, which makes it one of the more useful references for thinking about the app delivery question. The review noted heterogeneity in protocols and populations and called for standardized hypnosis protocols and larger RCTs. The honest read is that hypnosis helps for sleep in roughly half of the trials examined, which is positive and worth taking seriously. The other half did not show benefit, which is also worth taking seriously. CBT-I remains the first-line evidence-based treatment for chronic insomnia. Hypnosis is positioned as adjunctive intervention, not as monotherapy for chronic insomnia, regardless of delivery format.

Hammond 2010 (PMID 20183733) reviewed the evidence for hypnosis in the treatment of anxiety and stress-related disorders, concluding that hypnosis is an effective adjunctive intervention for generalized anxiety, situational anxiety, pre-procedural anxiety, and stress-related symptoms, with effect sizes comparable to other psychotherapeutic interventions. That review covers clinician-delivered hypnosis primarily. Direct evidence for app-only delivery in clinical anxiety is thinner. The honest framing for the reader is that clinician-delivered hypnotherapy for anxiety has a real evidence base, app delivery probably captures part of that benefit for mild presentations, and app delivery captures less of it for the more severe and complex anxiety cases that need personalization and troubleshooting. The page on hypnotherapy for anxiety where an app or in-person can both work covers that distinction in more depth.

Apps work better for some categories than others, and the pattern is consistent. Stress, sleep onset, and general focus support are categories where generic guided content has a reasonable chance of landing because the work is mostly state regulation. The target state is similar across users, so generic content fits. Conditions like OCD, PTSD, severe panic, and complex comorbidity stacks are categories where the work is mostly personalization. Generic content fits poorly because the target work is specific to the case. The honest summary is that an app is appropriate for the state-regulation end of the spectrum and inappropriate for the personalization-heavy end of the spectrum.

Per the scope-of-practice statement that I work to as a Registered Clinical Hypnotherapist, hypnotherapy is complementary care, not a replacement for medical or psychological treatment. An RCH does not diagnose mental or physical conditions, does not prescribe or adjust medication, and does not treat psychotic disorders, severe dissociative disorders, active suicidality, or untreated severe trauma as primary presentations. A self-hypnosis app operates with an even narrower scope, because there is no practitioner to do screening, no practitioner to refer out, and no practitioner to recognize when the app is the wrong tool. That is not an indictment of the app format. It is a reason to be honest about which presentations the format cannot serve.

Frequently asked questions

If you have read this far you have done more diligence than most people who are choosing between an app and in-person work. The practical next step depends on what you found. If your situation is mild, general, and an app trial has been producing real change, keep using the app. If your situation is IBS specifically, Nerva or Mahana are usually the better starting point than a generic hypnosis app, and the dedicated Reveri review for deeper analysis of where Reveri fits covers that comparison in more depth. If your situation has the markers of needing personalization, scope screening, or troubleshooting that an app cannot provide, a free consultation is the cheapest way to confirm that and plan the in-person work. You can start in-person intake when an app isn't enough whenever you are ready.